FSN Capital VI partners with Prange Group
FSN Capital VI (FSNC) has acquired a majority share in Adragos Pharma Group (Adragos), a B2B contract developer and manufacturer (CDMO) for pharmaceuticals. The current owner, Prange Group (PG), remains invested. The parties have agreed not to disclose details of the transaction. Adragos, with production sites in Livron (France), Leipzig